The first inhaled form of insulin, a product that could reduce or eliminate the daily injections needed by millions of diabetics, moved closer to federal approval yesterday.
An advisory panel to the Food and Drug Administration voted 7 to 2 to recommend approval of the drug for adults with either Type 1 or Type 2 diabetes, despite some concerns about the long-term effect that inhaling insulin would have on users' lungs.
